For years, the life sciences industry has been trying to address the same R&D challenges: rising costs, patient recruitment and retention, and difficulty maximizing ROI. Drug development is expensive, ...
Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...
An analysis of Investigational New Drug (IND) submissions to the US Food and Drug Administration (FDA) from 1995 to 2025 reveals a rapid growth in adeno-associated virus (AAV) development over three ...
Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
When developing new drugs or managing on-going drug performance, massive amounts of data need to be integrated and reviewed to ensure quality and oversight. However, healthcare data is often ...
High drug development costs, and a multi-year development cycle, can stress the budgets of even well-capitalized firms. Biotech expert Leen Kawas discussed the drivers of high drug development costs.
Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to accelerate one of the slowest and most challenging stages of cancer drug ...
Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. Traditional methods, while advancing, are hitting limits in tackling the complexities ...
As I reflect on how we can more effectively bring treatments to patients, one central question emerges: How can we transform scientific discoveries into better treatments? The intersection of science ...
Evan Feinberg founded Genesis Molecular AI seven years ago to take his research at Stanford on AI for drug discovery to the real world. Today the company announced its biggest partnership to date: A ...